| The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease J Budni, T Bellettini-Santos, F Mina, ML Garcez, AI Zugno Aging and disease 6 (5), 331, 2015 | 402 | 2015 |
| Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress M Moretti, A Colla, G de Oliveira Balen, DB dos Santos, J Budni, ... Journal of psychiatric research 46 (3), 331-340, 2012 | 229 | 2012 |
| CREB and BDNF: Neurobiology and treatment of Alzheimer's disease M Amidfar, J de Oliveira, E Kucharska, J Budni, YK Kim Life sciences, 118020, 2020 | 183 | 2020 |
| Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems PS Brocardo, J Budni, MP Kaster, ARS Santos, ALS Rodrigues Neuropharmacology 54 (2), 464-473, 2008 | 161 | 2008 |
| Nrf2 participates in depressive disorders through an anti-inflammatory mechanism MD Martín-de-Saavedra, J Budni, MP Cunha, V Gómez-Rangel, S Lorrio, ... Psychoneuroendocrinology 38 (10), 2010-2022, 2013 | 128 | 2013 |
| Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway T Dal-Cim, S Molz, J Egea, E Parada, A Romero, J Budni, ... Neurochemistry international 61 (3), 397-404, 2012 | 121 | 2012 |
| Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice M Moretti, J Budni, DB Dos Santos, A Antunes, JF Daufenbach, ... Journal of Molecular Neuroscience 49 (1), 68-79, 2013 | 105 | 2013 |
| Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice J Budni, AD Zomkowski, D Engel, DB Santos, AA dos Santos, M Moretti, ... Experimental neurology 240, 112-121, 2013 | 104 | 2013 |
| Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide–cGMP and PI3K/mTOR pathways LEB Bettio, MP Cunha, J Budni, FL Pazini, Á Oliveira, AR Colla, ... Behavioural brain research 234 (2), 137-148, 2012 | 99 | 2012 |
| Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system AE Freitas, J Budni, KR Lobato, RW Binfaré, DG Machado, J Jacinto, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (2), 335-343, 2010 | 89 | 2010 |
| Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia AI Zugno, HL Chipindo, AM Volpato, J Budni, AV Steckert, MB De Oliveira, ... Neuroscience 259, 223-231, 2014 | 88 | 2014 |
| Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice ML Garcez, F Mina, T Bellettini-Santos, FG Carneiro, AP Luz, GL Schiavo, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 77, 23-31, 2017 | 84 | 2017 |
| Neuroprotective effect of guanosine against glutamate‐induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol‐3 kinase/Akt/glycogen synthase kinase … S Molz, T Dal‐Cim, J Budni, MD Martín‐de‐Saavedra, J Egea, A Romero, ... Journal of neuroscience research 89 (9), 1400-1408, 2011 | 81 | 2011 |
| Contributions of animal models to the study of mood disorders SS Valvassori, J Budni, RB Varela, J Quevedo Brazilian Journal of Psychiatry 35, S121-S131, 2013 | 80 | 2013 |
| α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression KR Lobato, CC Cardoso, RW Binfaré, J Budni, CLR Wagner, PS Brocardo, ... Behavioural brain research 209 (2), 249-259, 2010 | 79 | 2010 |
| Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway M Moretti, J Budni, AE Freitas, PB Rosa, ALS Rodrigues Journal of psychiatric research 48 (1), 16-24, 2014 | 77 | 2014 |
| Antidepressant-like effect of folic acid: Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway P de Souza Brocardo, J Budni, KR Lobato, MP Kaster, ALS Rodrigues European journal of pharmacology 598 (1-3), 37-42, 2008 | 76 | 2008 |
| Involvement of nitric oxide–cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test M Moretti, AE de Freitas, J Budni, SCP Fernandes, G de Oliveira Balen, ... Behavioural brain research 225 (1), 328-333, 2011 | 75 | 2011 |
| The anti-inflammatory role of minocycline in Alzheimer s disease J Budni, M L Garcez, J Medeiros, E Cassaro, T Bellettini-Santos, F Mina, ... Current Alzheimer Research 13 (12), 1319-1329, 2016 | 73 | 2016 |
| Sodium butyrate functions as an antidepressant and improves cognition with enhanced neurotrophic expression in models of maternal deprivation and chronic mild stress S Silva Valvassori, R Bitencourt Varela, C Orlandi Arent, ... Current neurovascular research 11 (4), 359-366, 2014 | 71 | 2014 |
